ACC 2010 schedule

Here is the page we will use to coordinate interviews at ACC 2010

Filming location: Atlanta Marriott Downtown 160 Spring Street Atlanta, GA 30303 Filming will occur from Saturday to Tuesday (March 13 - March 16). Dr. Gibson is available to interview during all times listed in black. For all times listed  in green , Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.

Click on Date for Detailed Schedule
Saturday March 13, 2010

Sunday March 14, 2010

Monday March 15, 2010

Tuesday March 16, 2010

10:15 AM

 * Interviewee: Robert M. Califf
 * Trial: The Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

11:00 AM

 * Interviewee: Manesh R. Patel

4:30 PM

 * Interviewee: Hyo-Soo Kim
 * Trial: Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications after Drug-eluting Stent Implantation for Coronary Heart Disease: Influence of Cilostazol-based triple anti-platelet therapy on Ischemic Complication after drug-eluting stent implantation (CILON-T) study

Return to top

11:00 AM

 * Presenter: Mark Chan
 * Presentation: Temporal Trends Over 15 Years in Clinical Trials of Non-ST Elevation Acute Coronary Syndromes: More Aggressive Treatment Yields Similar Mortality Despite Higher-Risk Profiles

11:30 AM

 * Presenter: Freek.W.A. Verheugt

12:30 PM

 * Interviewee: Tracy Y. Wang
 * Presentation: Upfront Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Use in Patients with Acute Coronary Syndrome: An Analysis from the Early versus Delayed Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial

1:00 PM

 * Interviewee: Chiara Melloni
 * Presentation: Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients with Acute Coronary Syndromes and Reduced Renal Function

1:30 PM

 * Interviewee:
 * Trial:

2:00 PM

 * Interviewee: Francois Schiele
 * Trial: Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis

2:30 PM

 * Interviewee: Michael Maeng
 * Trial: Randomized All-comer Comparison of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents: 18-month Follow-up in the SORT OUT III Trial

3:00 PM

 * Interviewee: Michael D. Ezekowitz
 * Trial: A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation

3:30 PM

 * Interviewee: Gary Michael Felker
 * Trial: The Diuretic Optimization Strategies Evaluation (DOSE) Study: A Randomized, Double Blind, Placebo-controlled Trial Of Diuretic Strategies In Acute Decompensated Heart Failure

4:00 PM

 * Interviewee: George H. Crossley, III
 * Trial: The Impact of Remote Monitoring with Automatic Clinician Notifications on the clinical care of ICD and CRT-D Patients

5:00 PM

 * Interviewee: Henry Ginsberg
 * Trial: Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study

Return to top

8:00 AM

 * Interviewee: Rhonda M. Cooper-Dehoff
 * Trial: Rethinking Lower BP Goals for Diabetics with Documented Coronary Artery Disease: Findings from the INternational VErapamil SR - Trandolapril STudy (INVEST)

8:30 AM

 * Interviewee: Peter Clemmensen
 * Trial: Long-term Outcome after Drug-Eluting versus Bare-Metal Stent Implantation in Patients with ST-Elevation Myocardial Infarction. Three-year follow-up of the DEDICATION Trial

9:00 AM

 * Interviewee: Robert A. Byrne
 * Trial: Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes

9:30 AM

 * Interviewee: Steven Goldman
 * Trial: A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study

10:00 AM

 * Interviewee: Ted Feldman
 * Trial: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial

10:20 AM

 * Interviewee: Claes Held
 * Trial: Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From The PLATO Trial

1:00 PM

 * Interviewer:: Bimal Shah

2:15 PM

 * Interviewee: William C. Cushman
 * Trial: Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial

2:30 PM

 * Interviewee: Robert S. Epstein
 * Trial: Effect of Genotyping Warfarin Patients on Outcomes: Results from the National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES)

3:30 PM

 * Interviewee: Hisao Ogawa

4:00 PM

 * Interviewee: Hisao Ogawa
 * Presentation: Endo-PAT evaluation of Endothelia function

4:30 PM
Return to top

9:00 AM

 * Interviewer: Bimal R. Shah

9:30 AM

 * Interviewee: David Antoniucci
 * Trial: Randomized Comparison of Angiojet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients with Acute Myocardial Infarction: the Jetstent Trial

10:00 AM

 * Interviewee:
 * Trial:

Return to top